
Vol. 53, No. 4, 2007
Free Abstract
Article (References)
Article (PDF 175 KB)
Clinical Study
Sustained Virological Response in the Antiviral Therapy of Chronic Hepatitis C: Is There a Predictive Value of Interferon-Induced Depression?
Arne Schäfera, Michael Scheurlena, Benedikt Weissbrichb, Katrin Schöttkera, Michael R. Krausa
aDepartment of Gastroenterology and Hepatology, Medizinische Klinik und Poliklinik II and bInstitute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany
Address of Corresponding Author
Chemotherapy 2007;53:292-299 (DOI: 10.1159/000102584)
Key Words
- Hepatitis C
- Depression
- Sustained virological response
- Binary logistic regression
Abstract
Background: The study objective was to determine the contribution of cytokine-induced depression to a predictive model of sustained virological response (SVR) in chronic hepatitis C. Methods: One hundred and one therapy-naïve hepatitis C virus (HCV) outpatients received treatment with peginterferon alfa-2b and ribavirin. Neuropsychiatric side effects were monitored prospectively (Hospital Anxiety and Depression Scale, DSM-IV criteria for major depression). SVR was defined as a failure to detect HCV by PCR 24 weeks after therapy. Results: SVR rate was 72.3% (73 of 101 patients). Classification data and the extent of interferon-induced depression were not significantly linked to SVR. Virus genotype (p = 0.045) and gender (p = 0.016) contributed significantly to a logistic regression model. Mean (p = 0.811) and maximum (p = 0.744) depression increases were no significant predictors of SVR. Major depression rates (DSM-IV criteria) were 12.3% (9 of 73 patients) in the subgroup with SVR and 10.7% (3 of 28) in patients without SVR. Conclusions: We found no significant association between depression and the efficacy of antiviral treatment in chronic hepatitis C. Interferon-induced depressive symptoms are important to be monitored and treated if necessary; however, they cannot be used to predict therapy success. Copyright © 2007 S. Karger AG, Basel
Author Contacts Michael R. Kraus, MD, PhD Medizinische Klinik und Poliklinik II, University of Würzburg Klinikstrasse 6-8, DE-97070 Würzburg (Germany) Tel. +49 931 201 70170, Fax +49 931 201 70680 E-Mail kraus_m@klinik.uni-wuerzburg.de
Article Information
Received: February 3, 2005
Accepted after revision: May 8, 2006
Published online: May 10, 2007
Number of Print Pages : 8
Number of Figures : 1, Number of Tables : 4, Number of References : 27 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|